Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 1—January 2023
Research Letter

Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021

Stephanie J. Curtis1Comments to Author , Abdul W. Shah1, Ana Ratu, Donald J. Wilson, Philip C. Hill, Phil Hulcome, Cathy Gaylard, Daniel Faktaufon, Talica Cabemaiwai, Isireli Rabukawaqa, Tevita Qoriniasi, Akesh Narayan, Susana Nakalevu, Pablo Romakin, Jemesa Tudravu, James Fong2, and Nick Walsh2
Author affiliations: National Critical Care and Trauma Response Centre, Darwin, Northern Territory, Australia (S.J. Curtis, C. Gaylard, N. Walsh); Ministry of Health and Medical Services, Suva, Fiji (A.W. Shah, D. Faktaufon, T. Cabemaiwai, I. Rabukawaqa, T. Qoriniasi, A. Narayan, S. Nakalevu, P. Romakin, J. Tudravu, J. Fong); Fiji National University, Suva (A. Ratu, D.J. Wilson, P.C. Hill); University of Otago, Dunedin, New Zealand (P.C. Hill); Fiji Program Support Facility, Suva (P. Hulcome)

Main Article

Table

Participant characteristics from a rapid SARS-CoV-2 seroprevalence survey in Central and Western Divisions of Fiji, November–December 2021

Characteristics No. (%)* No. seropositive† Seroprevalence, % (95% CI)
Total
 539
 515
 95.5 (93.4–97.1)
Sex
M 255 (47.3) 246 96.5 (93.2–98.3)
F
 284 (52.7)
 269
 94.7 (91.3–97.0)
Age, years
8–11 51 (9.5) 36 70.6 (56.0–82.1)
12–17 73 (13.5) 66 90.4 (80.7–95.7)
18–29 132 (24.5) 132 100 (96.5–100)
30–39 143 (26.5) 141 98.6 (94.5–99.8)
40–49 96 (17.8) 96 100 (95.2–100)
>50
 44 (8.2)
 44
 100 (90.0–100)
Ethnicity
I-Taukei 269 (49.9) 259 96.3 (93.1–98.1)
Fijian of Indian descent 249 (46.2) 236 94.8 (91.0–97.1)
Fijian of other descent
 21 (3.9)
 20
 95.2 (74.1–99.8)
Occupation industry
Healthcare worker 158 (29.3) 157 99.4 (96.0–99.9)
Student 142 (26.3) 120 84.5 (77.3–89.8)
Transportation 94 (17.4) 94 100 (95.1–100)
Hotel 69 (12.8) 69 100 (93.4–100)
Education 40 (7.4) 39 97.5 (85.7–99.9)
Hospitality
 36 (6.7)
 36
 100 (88.0–100)
COVID-19 vaccine status
None 76 (14.1) 58 76.3 (64.9–85.0)
1 dose 20 (3.7) 16 80.0 (55.7–93.4)
2 doses
 443 (82.2)
 441
 99.5 (98.2–99.9)
Self-reported previous COVID-19
No 410 (76.1) 387 94.4 (91.6–96.3)
Yes 117 (21.7) 117 100 (96.0–100)
Unknown 12 (2.2) 11 91.7 (59.7–99.6)

*Percentage of total. †Number seropositive for SARS-CoV-2.

Main Article

1These first authors contributed equally to this article.

2These senior authors contributed equally to this article.

Page created: November 09, 2022
Page updated: December 22, 2022
Page reviewed: December 22, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external